BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34478946)

  • 21. Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.
    Sinha A; Tamboli RS; Seth B; Kanhed AM; Tiwari SK; Agarwal S; Nair S; Giridhar R; Chaturvedi RK; Yadav MR
    Mol Neurobiol; 2015 Aug; 52(1):638-52. PubMed ID: 25257697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models.
    Singh V; Kahol A; Singh IP; Saraf I; Shri R
    J Ethnopharmacol; 2016 Dec; 193():490-499. PubMed ID: 27725240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.
    Carles A; Hoffmann M; Scheiner M; Crouzier L; Bertrand-Gaday C; Chatonnet A; Decker M; Maurice T
    CNS Neurosci Ther; 2024 Jun; 30(6):e14814. PubMed ID: 38887858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-Ribose-L-cysteine attenuates lipopolysaccharide-induced memory deficits through inhibition of oxidative stress, release of proinflammatory cytokines, and nuclear factor-kappa B expression in mice.
    Emokpae O; Ben-Azu B; Ajayi AM; Umukoro S
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):909-925. PubMed ID: 31907583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects.
    Mirahmadi SM; Shahmohammadi A; Rousta AM; Azadi MR; Fahanik-Babaei J; Baluchnejadmojarad T; Roghani M
    Cytokine; 2018 Apr; 104():151-159. PubMed ID: 29102164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Alzheimer's Studies on β-Sitosterol Isolated from
    Ayaz M; Junaid M; Ullah F; Subhan F; Sadiq A; Ali G; Ovais M; Shahid M; Ahmad A; Wadood A; El-Shazly M; Ahmad N; Ahmad S
    Front Pharmacol; 2017; 8():697. PubMed ID: 29056913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer's Disease.
    Hira S; Saleem U; Anwar F; Sohail MF; Raza Z; Ahmad B
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
    Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
    Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
    Dash UC; Swain SK; Kanhar S; Banjare P; Roy PP; Dandapat J; Sahoo AK
    J Ethnopharmacol; 2022 Jan; 282():114637. PubMed ID: 34534598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory restorative ability of clioquinol in copper-cholesterol-induced experimental dementia in mice.
    Mehra R; Sodhi RK; Aggarwal N
    Pharm Biol; 2015; 53(9):1250-9. PubMed ID: 25856695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel quinazolinone Derivatives: Design, synthesis and in vivo evaluation as potential agents targeting Alzheimer disease.
    Moftah HK; Mousa MHA; Elrazaz EZ; Kamel AS; Lasheen DS; Georgey HH
    Bioorg Chem; 2024 Feb; 143():107065. PubMed ID: 38150939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease.
    Wang SW; Yang SG; Liu W; Zhang YX; Xu PX; Wang T; Ling TJ; Liu RT
    Behav Brain Res; 2016 Jan; 296():109-117. PubMed ID: 26358659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usnic acid enantiomers restore cognitive deficits and neurochemical alterations induced by Aβ
    Cazarin CA; Dalmagro AP; Gonçalves AE; Boeing T; Silva LMD; Corrêa R; Klein-Júnior LC; Pinto BC; Lorenzett TS; Sobrinho TUDC; Fátima Â; Lage TCA; Fernandes SA; Souza MM
    Behav Brain Res; 2021 Jan; 397():112945. PubMed ID: 33022354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD.
    Liu Y; Chen Z; Li B; Yao H; Zarka M; Welch J; Sachdev P; Bridge W; Braidy N
    Neurochem Int; 2021 Mar; 144():104931. PubMed ID: 33276023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat.
    Khajevand-Khazaei MR; Ziaee P; Motevalizadeh SA; Rohani M; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
    Eur J Pharmacol; 2018 May; 826():114-122. PubMed ID: 29518393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
    Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.
    Viayna E; Coquelle N; Cieslikiewicz-Bouet M; Cisternas P; Oliva CA; Sánchez-López E; Ettcheto M; Bartolini M; De Simone A; Ricchini M; Rendina M; Pons M; Firuzi O; Pérez B; Saso L; Andrisano V; Nachon F; Brazzolotto X; García ML; Camins A; Silman I; Jean L; Inestrosa NC; Colletier JP; Renard PY; Muñoz-Torrero D
    J Med Chem; 2021 Jan; 64(1):812-839. PubMed ID: 33356266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.